Presenting psychiatric and cognitive disorders in adult neurolipidoses;Manifestations psychiatriques ou cognitives inaugurales dans les neurolipidoses de l'adulte

Revue Neurologique

Volumn 159, Issue 6-7 I, 2003, Pages 637-647

  Turpin, J C ^a   Baumann, N ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADRENOLEUKODYSTROPHY; AUTOSOMAL DOMINANT DISORDER; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXPERIENCE; FABRY DISEASE; GENE MUTATION; GM2 GANGLIOSIDOSIS; HOMOCYSTINURIA; HUMAN; IMAGE ANALYSIS; INTELLECTUAL IMPAIRMENT; KUFS DISEASE; LIPIDOSIS; LYSOSOME; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MENTAL DISEASE; METACHROMATIC LEUKODYSTROPHY; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NIEMANN PICK DISEASE; PATHOPHYSIOLOGY; PEROXISOME; REVIEW; WILSON DISEASE;

ADOLESCENT; ADULT; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NIEMANN-PICK DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 0242432592     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. ABBOTT MH, FOLSTEIN SE, ABBEY H, PYERITZ RE. (1987). Psychiatric manifestations of homocystinuria due to cystathionine-beta-synthase deficiency: prevalence, natural history and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet, 26: 959-969.
2. AKIL M, SCHWARTZ JA, DUTCHAK D, YUZBASIYAN-GURKAN V, BREWER GJ. (1991). The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci, 3: 377-382.
3. BARBEY F, LIDOVE O, DROZ D, GRUNFELD JP. (2000). Maladie de Fabry: aspects cliniques et perspectives thérapeutiques. Schweiz Med Wochensch, 130: 763-771.
4. BAUMANN N, MASSON M, CARREAU V, LEFEVRE M, TURPIN JC. (1991). Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Dev Neurosci, 13: 201-215.
5. BAUMANN N, TURPIN JC. (2000). Adult-onset leukodystrophies. J Neurol, 247: 751-759.
6. BAUMANN N, GELOT A, TURPIN JC. (2002). Manifestations nerveuses des lipidoses. Encycl. Méd. Chir. Elsevier Paris. Neurologie, 17-162-D-10. 37 p.
7. BERGINER VM, FOSTER NL, SADOWSKY M, TOWNSEND III JA, SIEGEL GJ, SALEN G. (1988). Psychiatric disorders in cerebrotendinous xanthomatosis. Am J Psychiatry, 145: 354-357.
8. BERKOVIC SF, CARPENTER S, ANDERMANN F, ANDERMANN E, WOLFE LS. (1988). Kufs disease: a critical reappraisal. Brain, 111: 27-62.
9. BRAULT JL, GIESELMANN V, CARPENTIER A, LEFEVRE M, TURPIN JC, BAUMANN N. (1997). Deux cas familiaux de leucodystrophie métachromatique à expression tardive. Rev Neurol (Paris), 3: 193-196.
10. BRION S, MIKOL J, GRAVELEAU J. (1970). Leucodystrophie métachromatique de l'adulte jeune. Étude clinique, biologique et ultrastructurale. Rev Neurol (Paris), 122: 161-176.
11. BURGOVNE K, SWARTZ R, ANANTH J. (1995). Porphyria: reexamination of psychiatric implications. Psychother Psychosom, 64: 121-130.
12. CAMPO JV, STOWE R, SLOMKA G, BYLER D, GRACIOUS B. (1998). Psychosis as a presentation of physical disease in adolescence: a case of Niemann-Pick disease type C. Dev Med Child Neurol, 40: 126-129.
13. DENING TR, BERRIOSS GE. (1989). Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry, 46: 1126-1134.
14. th edition. NY, Mcgraw Hill, pp 2741-2784.
15. DESNUELLE C, PELISSIER JF, SERRATRICE G, POUGET J, TURNBULL DM. (1989). Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the respiratory chain. Rev Neurol (Paris), 145: 842-850.
16. DOTTI MT, SALEN G, FEDERICO A. (1991). Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature aging. Dev Neurosci, 13: 371-376.
17. DUBOIS G, TURPIN JC, GEORGES MC, BAUMANN N. (1980). Arylsulfatases A and B in leukocytes: A comparative statistical study of late infantile and juvenile forms of Metachromatic Leukodystrophy and Controls. Biomedicine, 33: 2-4.
18. FOONG J, MAIER M, BARKER GJ, BROCKLEHURST S, MILLER DH, RON MA. (2000). In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry, 68: 70-74.
19. GARSIDE S, ROSEBUSH PI, LEVINSON AJ, MAZUREK MF. (1999). Late-onset adrenoleukodystrophy associated with long-standing psychiatric symptoms. J Clin Psychiatry, 60: 460-468.
20. GIESELMANN V, ZLOTOGORA J, HARRIS A, WENGER D, MORRIS CP. (1994). Molecular genetics of metachromatic leukodystrophy. Hum Mutat, 4: 233-243.
21. GOEBEL HH, SHARP JD. (1998). The neuronal ceroid lipofuscinoses. Recent advances. Brain Pathology, 8: 151-162.
22. GOLD R, BOGDAHN U, KAPPOS L, TOYKA KV, BAUMGARTNER ER, FOWLER B, WANDEL U. (1996). Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. J Neurol Neurosurg Psychiatry, 60: 107-108.
23. GREWAL RP, BARTON NW. (1992). Fabry's disease presenting with stroke. Clin Neurol Neurosurg, 94: 117-179.
24. GREWAL RP. (1993). Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry, 23: 307-312.
25. HALSALL DJ, HALLIGAN EP, ELSEY TS, Cox TM. (1999). Metachromatic leukodystrophy: a newly identified mutation in arylsulphatase A, D281Y found as a compound heterozygote with I179S in an adult onset case. Hum Mutat, 14: 447.
26. HARRIS JG, FILLEY CM. (2001). CADASIL: neuropsychological findings in three generations of an affected family. J Int Neuropsychol Soc, 7: 768-774.
27. HERMANN S, SCHESTAG F, POLTEN A, KAFERT S, PENZIEN J, ZLOTOGORA J, BAUMANN N, GIESELMANN V. (2000). Characterization of four arylsulfatase A missense mutations G86D, Y201C, D255H, and E312D causing metachromatic leukodystrophy. Am J Med Genet 91: 68-73
28. HYDE TM, ZIEGLER JC, WEINBERGER DR. (1992). Psychiatric disturbances in metachromatic leukodystrophy. Arch Neurol, 49: 401-406.
29. JOSEPHSON SA, SCHMIDT RE, MILLSAP P, MCMANUS DQ, MORRIS JC. (2001). Autosomal dominant Kufs disease: a cause of early onset dementia. J Neurol Sci, 188: 51-60.
30. JULIEN J, LYON-CAEN O, BAUMANN N, BAUMELOU A. (1989). Accidents ischémiques cérébraux et insuffisance rénale chez un homme jeune. Rev Neurol (Paris), 145: 813-818.
31. KAIDO M, FUJIMURA H, SOGA F, et al. (1996). Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neuropathol (Berl), 92: 312-318.
32. LIDOVE O. Maladie de Fabry, 34 cas: manifestations cardiaques, neurologiques et psychiatriques. Thèse de Médecine, Université Paris XIII, 1998.
33. LIDOVE O, JOLY D, BARBEY F, BLETRY O, GRUNFELD JP. (2001). La maladie de Fabry chez l'adulte: aspects cliniques et progrès thérapeutiques. Rev Med Int, 22: 384-392.
34. LISTON EH, LEVINE MD, PHILIPPART M. (1973). Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiat, 29: 402-403.
35. LOSSOS A, SCHLESINGER I, OKON E, ABRAMSKY O, BARGAL R, VANIER MT, ZIEGLER M. (1997.) Adult onset Niemann-Pick type C disease: clinical, biochemical and genetic studies. Arch Neurol, 54: 1536-1541.
36. LYON-CAEN O, BENOIT N, CARREAU V, et al. (1991). Cognitive function in adult adrenoleukodystrophy: comparison with leukoaraiosis and Multiple Sclerosis. Dev Neurosci, 13: 251-253.
37. MACQUEEN GM, ROSEBUSH PL, MAZUREK MF. (1998). Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiat, 10: 10-19.
38. MIKOL J, HÉNIN D, BAUDRIMONT M, GAULIER A, BACRI D, TILLIER JN, DAVOUS P. (2001). CADASIL: aspects phénotypiques inhabituels et observations anatomo-pathologiques dans deux nouvelles familles françaises. Rev Neurol (Paris), 157: 655-667.
39. MOSER HW, MOSER AB, NAIDU S, BERGIN A. (1991). Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci, 13: 254-261.
40. NAVON R, KHOSRAVI R, KORCZYN T, et al. (1995). New mutation associated with b1 variant of chronic GM2 gangliosidosis. Neurology, 45: 539-543.
41. ROSEBUSH PI, MACQUEEN GM, CLARKE JTR, CALLAHAN JW, STRASBERG PM, MAZUREK MF. (1995). Late onset. Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry, 56: 347-353
42. SCHREINER R, BECKER J, WIEGAND MH. (2000). Kufs disease: a rare cause of early onset dementia. Nervenarzt, 71: 411-415.
43. SERENI C, RUEL M, IBA-ZIZEN MT, BAUMANN N, MARTEAU R, PATUR. NEAU-JOUAS M. (1987). Adult adrenoleukodystrophy: A sporadic case? J Neurol Sci, 80: 121-128.
44. SHULMAN LM, DAVID NJ, WEINER W. (1995). Psychosis as the initial manifestation of adult onset Niemann-Pick disease type C. Neurology, 45: 1739-1742.
45. SWIFT RG, SADLER DB, SWIFT M. (1990). Psychiatric findings in Wolfram syndrome homozygotes. Lancet, 336: 667-669.
46. TORRES R, LEROY E, Hu X et al. (2001). Mutation screening of the Wolfram syndrome gene in psychiatric patients. Mol Psychiatry, 6: 49-43.
47. TURPIN JC, GROSS JC. (1993). Adrénomyéloneuropathie évoluant comme une maladie psychiatrique. L'Encéphale 19: 609-613.
48. TYLKI-SZYMANSKA A, BERGER J, LOESCHL B, LUGOWSKA A, MOLZER B. (1996). Late juvenile metachromatic leukodystrophy (MLD) in three patients with asimilar course and identical mutation on one allele. Clin Genet, 50: 287-292.
49. VAN DIGGELEN OP, THOBOIS S, TILIKETE C et al. (2001). Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult onset patient of a childhood disease. Ann Neurol, 50: 269-272.
50. VANIER MT, RODRIGUEZ-LAFRASSE C, ROUSSON R et al. (1991). Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci, 13: 307-414.
51. WENGER DA, WILLIAMS C. (1991). Screening for lysosomal disorders. Techniques in Diagnostic Human Biochemical Genetics. A Laboratory Manual. (F.A.Hommes ed) Wiley-Liss Inc. 1991, pp 587-617.